Cubist Systematic Strategies, LLC - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260706. A total of 88 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q4 2021$3,000
-40.0%
7,7000.0%0.00%
Q3 2021$5,000
-81.5%
7,700
-63.0%
0.00%
Q1 2021$27,00020,8010.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q4 2021
NameSharesValueWeighting ↓
GSA CAPITAL PARTNERS LLP 1,781,617$637,0000.08%
Anson Funds Management LP 864,322$309,0000.03%
Virtu Financial LLC 307,275$110,0000.01%
D. E. Shaw & Co., Inc. 18,680,699$6,682,0000.01%
Renaissance Technologies 10,699,831$3,827,0000.01%
Point72 Hong Kong Ltd 348,383$125,0000.00%
MONECO Advisors, LLC 35,000$7,0000.00%
Purus Wealth Management, LLC 15,000$5,0000.00%
PRUDENTIAL FINANCIAL INC 6,929,345$2,479,0000.00%
ALPS ADVISORS INC 548,866$196,0000.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders